MCQ Quiz: Individualized Dosing of Antibiotics

Effective antimicrobial therapy is far more nuanced than simply selecting a drug from a list. The modern pharmacist knows that individualized dosing is critical to maximizing efficacy while minimizing toxicity. Tailoring antibiotic regimens based on patient-specific parameters, pharmacokinetic (PK) principles, and pharmacodynamic (PD) targets is a core responsibility of the pharmacy profession. This skill is honed throughout the PharmD curriculum, from foundational courses like Principles of Drug Therapy Individualization (PHA5132) to hands-on labs like Professional Skills Lab 3 (PHA5163L), where dosing complex drugs like vancomycin and aminoglycosides is practiced. This quiz will test your ability to apply these critical principles to ensure every patient receives a safe and effective, individualized antibiotic dose.

1. The pharmacodynamic parameter that best predicts the efficacy of vancomycin is:

  • a. Cmax/MIC
  • b. T > MIC
  • c. AUC/MIC
  • d. The post-antibiotic effect

Answer: c. AUC/MIC

2. For which class of antibiotics is time-dependent killing (T > MIC) the most important pharmacodynamic parameter?

  • a. Aminoglycosides
  • b. Beta-lactams
  • c. Fluoroquinolones
  • d. Daptomycin

Answer: b. Beta-lactams

3. When dosing aminoglycosides using the extended-interval (once-daily) method, what is the primary goal?

  • a. To keep the drug concentration above the MIC for the entire dosing interval.
  • b. To achieve a high peak concentration (Cmax) well above the MIC to take advantage of concentration-dependent killing.
  • c. To maintain a steady-state concentration.
  • d. To minimize the volume of distribution.

Answer: b. To achieve a high peak concentration (Cmax) well above the MIC to take advantage of concentration-dependent killing.

4. A pharmacist is asked to recommend an appropriate individualized dosing regimen for vancomycin. This is a key learning objective in which course?

  • a. PHA5781 Patient Care 1
  • b. PHA5163L Professional Skills Lab 3
  • c. PHA5104 Sterile Compounding
  • d. PHA5439 Principles of Medicinal Chemistry and Pharmacology I

Answer: b. PHA5163L Professional Skills Lab 3

5. According to current guidelines for serious MRSA infections, what is the target AUC/MIC ratio for vancomycin?

  • a. >125
  • b. 200-300
  • c. 400-600
  • d. >1000

Answer: c. 400-600

6. Which of the following patient-specific parameters is essential for calculating an initial vancomycin or aminoglycoside dose?

  • a. Hair color
  • b. Blood type
  • c. Renal function (e.g., creatinine clearance)
  • d. Past surgical history

Answer: c. Renal function (e.g., creatinine clearance)

7. The post-antibiotic effect (PAE), where bacterial growth remains suppressed even after the drug concentration falls below the MIC, is a prominent feature of which antibiotic class?

  • a. Penicillins
  • b. Cephalosporins
  • c. Macrolides
  • d. Aminoglycosides

Answer: d. Aminoglycosides

8. The Hartford nomogram is a tool used for monitoring which type of antibiotic dosing?

  • a. Traditional vancomycin dosing
  • b. Extended-interval aminoglycoside dosing
  • c. Oral beta-lactam dosing
  • d. Once-daily linezolid dosing

Answer: b. Extended-interval aminoglycoside dosing

9. Aminoglycosides exhibit concentration-dependent killing. This means:

  • a. The duration of exposure is more important than the dose.
  • b. The rate and extent of bacterial killing increase as the peak drug concentration increases relative to the MIC.
  • c. The drug is only effective at a single, specific concentration.
  • d. The drug’s efficacy depends on the patient’s serum albumin level.

Answer: b. The rate and extent of bacterial killing increase as the peak drug concentration increases relative to the MIC.

10. When dosing a renally-eliminated antibiotic in a patient with chronic kidney disease, what adjustment is most commonly made?

  • a. Increasing the dose.
  • b. Decreasing the dose or extending the dosing interval.
  • c. Switching to an IV formulation.
  • d. Administering the drug with food.

Answer: b. Decreasing the dose or extending the dosing interval.

11. The Cockcroft-Gault equation is commonly used by pharmacists to estimate:

  • a. Hepatic clearance
  • b. Volume of distribution
  • c. Creatinine clearance
  • d. Minimum inhibitory concentration

Answer: c. Creatinine clearance

12. A major toxicity associated with long-term or high-dose aminoglycoside therapy is:

  • a. Hepatotoxicity
  • b. Cardiotoxicity
  • c. Nephrotoxicity and Ototoxicity
  • d. Pulmonary fibrosis

Answer: c. Nephrotoxicity and Ototoxicity

13. Historically, vancomycin dosing was adjusted to target a specific trough concentration. Why has the focus shifted to AUC/MIC monitoring?

  • a. Trough monitoring was found to be a poor predictor of efficacy and is more strongly linked to nephrotoxicity than AUC.
  • b. AUC/MIC monitoring is cheaper.
  • c. Drawing trough levels is more difficult than drawing AUC levels.
  • d. Trough goals were consistently too low.

Answer: a. Trough monitoring was found to be a poor predictor of efficacy and is more strongly linked to nephrotoxicity than AUC.

14. Which patient weight should be used to calculate the vancomycin dose for most obese patients?

  • a. Ideal body weight
  • b. Adjusted body weight
  • c. Total body weight
  • d. Lean body weight

Answer: c. Total body weight

15. A loading dose of vancomycin is sometimes given to:

  • a. Decrease the risk of toxicity.
  • b. Achieve the target therapeutic concentration more rapidly in seriously ill patients.
  • c. Test for an allergic reaction.
  • d. Reduce the cost of therapy.

Answer: b. Achieve the target therapeutic concentration more rapidly in seriously ill patients.

16. The ability to recommend antibiotic therapy based on patient-specific parameters like kidney function and culture data is a key student objective.

  • a. True
  • b. False

Answer: a. True

17. For a patient on intermittent hemodialysis, when should a dose of a dialyzable antibiotic like gentamicin typically be administered?

  • a. Immediately before a dialysis session.
  • b. During the dialysis session.
  • c. After a dialysis session.
  • d. The timing does not matter.

Answer: c. After a dialysis session.

18. What does “MIC” stand for in the context of antibiotic therapy?

  • a. Maximum Inhibitory Concentration
  • b. Minimum Inhibitory Concentration
  • c. Mean Infusion Concentration
  • d. Metabolic Induction Capacity

Answer: b. Minimum Inhibitory Concentration

19. When using the Hartford nomogram, a random drug level is drawn how many hours after the start of the aminoglycoside infusion?

  • a. 2-4 hours
  • b. 6-14 hours
  • c. 18-24 hours
  • d. 30 minutes before the next dose

Answer: b. 6-14 hours

20. A patient’s vancomycin trough level comes back higher than the goal range. The most appropriate action is to:

  • a. Increase the dose.
  • b. Decrease the frequency (extend the interval) or decrease the dose.
  • c. Continue the current regimen and recheck in 48 hours.
  • d. Switch to a different antibiotic immediately.

Answer: b. Decrease the frequency (extend the interval) or decrease the dose.

21. The two main pharmacokinetic parameters that determine a drug’s half-life are:

  • a. Absorption rate and MIC
  • b. Volume of distribution and Clearance
  • c. Peak and Trough
  • d. Dose and frequency

Answer: b. Volume of distribution and Clearance

22. Which antibiotic class is associated with the “Red Man Syndrome” infusion reaction?

  • a. Fluoroquinolones
  • b. Aminoglycosides
  • c. Glycopeptides (Vancomycin)
  • d. Macrolides

Answer: c. Glycopeptides (Vancomycin)

23. Therapeutic Drug Monitoring (TDM) is most necessary for drugs with a:

  • a. Wide therapeutic index and predictable dose-response.
  • b. Narrow therapeutic index and significant pharmacokinetic variability.
  • c. Low risk of toxicity.
  • d. Short half-life.

Answer: b. Narrow therapeutic index and significant pharmacokinetic variability.

24. The volume of distribution (Vd) of a drug describes:

  • a. The rate at which the drug is eliminated from the body.
  • b. The theoretical volume that would be necessary to contain the total amount of an administered drug at the same concentration that it is observed in the blood plasma.
  • c. The drug’s ability to kill bacteria.
  • d. The drug’s protein binding percentage.

Answer: b. The theoretical volume that would be necessary to contain the total amount of an administered drug at the same concentration that it is observed in the blood plasma.

25. A patient with a CrCl of 25 mL/min needs to be started on an antibiotic that is 90% renally eliminated. The standard dose is 500 mg every 8 hours. Which is the most appropriate initial adjustment?

  • a. 500 mg every 6 hours
  • b. 1000 mg every 8 hours
  • c. 500 mg every 24 hours
  • d. No dose adjustment is needed.

Answer: c. 500 mg every 24 hours

26. Individualizing the dose of aminoglycosides is an objective in the Professional Skills Lab.

  • a. True
  • b. False

Answer: a. True

27. For time-dependent antibiotics like piperacillin-tazobactam, what dosing strategy can be used to maximize T > MIC, especially for organisms with high MICs?

  • a. Giving a larger dose once a day.
  • b. Administering the drug as a continuous or extended infusion.
  • c. Giving the drug with a high-fat meal.
  • d. Administering the dose as a rapid IV push.

Answer: b. Administering the drug as a continuous or extended infusion.

28. Why is it difficult to create a standard formula for antibiotic dose adjustments in patients with hepatic impairment?

  • a. Liver function is not important for drug elimination.
  • b. All antibiotics are eliminated by the kidneys.
  • c. There is no single lab value that accurately reflects the liver’s overall metabolic capacity, unlike CrCl for the kidneys.
  • d. The liver can regenerate, so adjustments are never needed.

Answer: c. There is no single lab value that accurately reflects the liver’s overall metabolic capacity, unlike CrCl for the kidneys.

29. The Child-Pugh score is used to assess the severity of:

  • a. Renal dysfunction
  • b. Cardiac failure
  • c. Liver disease
  • d. Acute infection

Answer: c. Liver disease

30. Which of the following is an example of a concentration-dependent antibiotic?

  • a. Penicillin G
  • b. Ceftriaxone
  • c. Levofloxacin
  • d. Clindamycin

Answer: c. Levofloxacin

31. A pharmacist calculates a vancomycin maintenance dose. The calculation relies on which two patient-specific pharmacokinetic parameters?

  • a. Patient’s age and height
  • b. Patient’s estimated vancomycin clearance and volume of distribution
  • c. Patient’s serum albumin and bilirubin
  • d. Patient’s temperature and blood pressure

Answer: b. Patient’s estimated vancomycin clearance and volume of distribution

32. Attaining a steady state concentration for a drug generally takes how many half-lives?

  • a. 1-2
  • b. 3-5
  • c. 7-10
  • d. More than 10

Answer: b. 3-5

33. When should a trough level for vancomycin or traditional aminoglycosides be drawn?

  • a. Immediately after the dose is given.
  • b. 2 hours after the infusion ends.
  • c. Immediately before the next scheduled dose (usually the 4th dose).
  • d. At a random time during the day.

Answer: c. Immediately before the next scheduled dose (usually the 4th dose).

34. The term “clearance” in pharmacokinetics refers to:

  • a. The time it takes for the drug concentration to decrease by half.
  • b. The theoretical volume of fluid cleared of a drug per unit of time.
  • c. The amount of drug in the body.
  • d. The drug’s binding affinity to plasma proteins.

Answer: b. The theoretical volume of fluid cleared of a drug per unit of time.

35. A patient has a Staph aureus infection with a vancomycin MIC of 2 mcg/mL. This is clinically significant because:

  • a. It is very easy to treat this infection.
  • b. It is difficult to achieve the target AUC/MIC of 400-600 without risking nephrotoxicity, and alternative agents should be considered.
  • c. Vancomycin is not active against Staph aureus.
  • d. This MIC indicates the infection is actually MSSA.

Answer: b. It is difficult to achieve the target AUC/MIC of 400-600 without risking nephrotoxicity, and alternative agents should be considered.

36. Dosing in special patient populations is a key concept for drug individualization.

  • a. True
  • b. False

Answer: a. True

37. When dosing an aminoglycoside in an obese patient, which weight is typically used to calculate the dose?

  • a. Total body weight
  • b. Ideal body weight
  • c. Adjusted body weight
  • d. The weight does not matter.

Answer: c. Adjusted body weight

38. The goal of drawing a peak level for traditionally-dosed aminoglycosides is to assess:

  • a. The risk of nephrotoxicity.
  • b. The drug’s distribution.
  • c. The adequacy of the dose for achieving bactericidal concentrations.
  • d. The patient’s adherence.

Answer: c. The adequacy of the dose for achieving bactericidal concentrations.

39. For a highly protein-bound antibiotic, a decrease in a patient’s serum albumin may lead to:

  • a. A decrease in the free (active) fraction of the drug.
  • b. An increase in the free (active) fraction of the drug, potentially increasing its effect and toxicity.
  • c. No change in the drug’s activity.
  • d. A decrease in the drug’s half-life.

Answer: b. An increase in the free (active) fraction of the drug, potentially increasing its effect and toxicity.

40. A time-dependent antibiotic is most effective when the drug concentration is maintained:

  • a. As high as possible for a short time.
  • b. Below the MIC.
  • c. Above the MIC for a significant portion of the dosing interval.
  • d. At a constant level equal to the peak.

Answer: c. Above the MIC for a significant portion of the dosing interval.

41. The primary mechanism of vancomycin toxicity is:

  • a. Cardiotoxicity
  • b. Hepatotoxicity
  • c. Nephrotoxicity
  • d. Neurotoxicity

Answer: c. Nephrotoxicity

42. Which of the following equations is used to calculate a drug’s half-life (t1/2)?

  • a. t1/2 = 0.693 / ke
  • b. t1/2 = Vd * ke
  • c. t1/2 = Dose / AUC
  • d. t1/2 = 0.5 * Cmax

Answer: a. t1/2 = 0.693 / ke

43. A patient’s culture and sensitivity report is crucial for individualized antibiotic therapy because it:

  • a. Provides the definitive identity of the infecting organism and its susceptibility (MIC) to various antibiotics.
  • b. Determines the patient’s renal function.
  • c. Lists the patient’s medication allergies.
  • d. Shows the patient’s insurance information.

Answer: a. Provides the definitive identity of the infecting organism and its susceptibility (MIC) to various antibiotics.

44. What is a key reason for using extended-interval dosing for aminoglycosides?

  • a. It is more expensive than traditional dosing.
  • b. It takes advantage of the drug’s concentration-dependent killing and PAE while potentially reducing nephrotoxicity by providing a longer drug-free interval.
  • c. It is less effective than traditional dosing.
  • d. It requires more frequent blood draws.

Answer: b. It takes advantage of the drug’s concentration-dependent killing and PAE while potentially reducing nephrotoxicity by providing a longer drug-free interval.

45. If you need to calculate a new vancomycin dose using two steady-state levels (e.g., a peak and a trough), you are using which method?

  • a. A population kinetics model
  • b. A Bayesian model
  • c. A patient-specific pharmacokinetic parameter model
  • d. The Hartford nomogram

Answer: c. A patient-specific pharmacokinetic parameter model

46. Which of the following drugs requires the most intensive therapeutic drug monitoring in the hospital setting?

  • a. Amoxicillin
  • b. Azithromycin
  • c. Vancomycin
  • d. Cephalexin

Answer: c. Vancomycin

47. The term “empiric therapy” refers to:

  • a. Antibiotic therapy directed at a known pathogen.
  • b. Antibiotic therapy initiated based on the most likely pathogens before culture results are available.
  • c. Antibiotic therapy that has been proven ineffective.
  • d. Non-prescription antibiotic therapy.

Answer: b. Antibiotic therapy initiated based on the most likely pathogens before culture results are available.

48. Why would a loading dose for a drug with a long half-life be beneficial?

  • a. It allows the drug to be eliminated faster.
  • b. It reduces the time required to reach steady-state concentrations.
  • c. It decreases the volume of distribution.
  • d. It increases the drug’s clearance.

Answer: b. It reduces the time required to reach steady-state concentrations.

49. For beta-lactam antibiotics, a common pharmacodynamic target is for the free drug concentration to be above the MIC for what percentage of the dosing interval?

  • a. 10-20%
  • b. 40-70%
  • c. 90-100%
  • d. The percentage does not matter.

Answer: b. 40-70%

50. The ultimate goal of individualized antibiotic dosing is to:

  • a. Use the most expensive antibiotic available.
  • b. Give every patient the same standard dose.
  • c. Optimize clinical outcomes for the patient while minimizing the risks of toxicity and the development of resistance.
  • d. Complete the TDM process as quickly as possible.

Answer: c. Optimize clinical outcomes for the patient while minimizing the risks of toxicity and the development of resistance. Sources

profile picture

Generate Audio Overview

Author

  • G S Sachin Author Pharmacy Freak
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators